Imexpharm Corp (IMP) — Strategic Asset Allocation Index
Imexpharm Corp (IMP) has a Strategic Asset Allocation Index of 46.0% as of September 2023. Strategic assets (PP&E of ₫924.94 Billion plus long-term investments of ₫-) total ₫924.94 Billion, measured against net assets of ₫2.01 Trillion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Imexpharm Corp Strategic Asset Allocation Index (2019–2022)
This chart shows how Imexpharm Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2023, the index stands at 46.0%, representing strategic assets of ₫924.94 Billion against net assets of ₫2.01 Trillion VND. Explore cash efficiency ratio of Imexpharm Corp to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Imexpharm Corp (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Imexpharm Corp from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Imexpharm Corp (IMP) market capitalisation.
| Year | SAAI | Strategic Assets (VND) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 52.6% | ₫996.45 Billion | ₫996.45 Billion | ₫- | ₫1.89 Trillion | ▼ -0.7 pp |
| 2021 | 53.3% | ₫955.68 Billion | ₫955.68 Billion | ₫- | ₫1.79 Trillion | ▼ -1.6 pp |
| 2020 | 54.8% | ₫949.15 Billion | ₫949.15 Billion | ₫- | ₫1.73 Trillion | ▼ -2.6 pp |
| 2019 | 57.5% | ₫896.18 Billion | ₫896.18 Billion | ₫- | ₫1.56 Trillion | — |